Portfolio Details

AiCure

Current

New York based AiCure uses artificial intelligence to visually confirm medication ingestion. The clinically-validated platform works on smartphones to reduce risk and optimize patient behavior.

Learn more about the company

Current

Team: Venture Capital
Invested Date: July 2017
Status: Active
Location: U.S.

See All Transactions

Related Content

Abstract image containing lines and streaks of color.

Baird Capital Portfolio Company AiCure Raises $24.5M in Series C Funding Round

AiCure uses artificial intelligence to see, hear and understand how people respond to treatment across clinical trials and patient care.